Research and Markets: Staphylococcal Infections Pipeline Insights - Complete Pipeline intelligence and Complete Understanding Over Therapeutics Development for Staphylococcal Infections

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/rxjsbd/staphylococcal) has announced the addition of the "Staphylococcal Infections-Pipeline Insights" report to their offering.

This Staphylococcal Infections-Pipeline Insights, 2014, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Staphylococcal Infections. This report provides information on the therapeutic development based on the Staphylococcal Infections dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.

The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Staphylococcal Infections
  • The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
  • Coverage of the Staphylococcal Infections pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
  • The report reviews key players involved in the therapeutics development for Staphylococcal Infections and also provide company profiling
  • The report also gives the information of dormant and discontinued pipeline projects
  • Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
  • Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

Key Topics Covered:

  • Staphylococcal Infections Overview
  • Staphylococcal Infections Pipeline Therapeutics
  • Staphylococcal Infections Therapeutics under Development by Companies
  • Staphylococcal Infections Late Stage Products (Filed and Phase III)
  • Comparative Analysis
  • Staphylococcal Infections Mid Clinical Stage Products (Phase II)
  • Comparative Analysis
  • Staphylococcal Infections Early Clinical Stage Products (Phase I and IND Filed)
  • Comparative Analysis
  • Staphylococcal Infections Discovery and Pre-Clinical Stage Products
  • Comparative Analysis
  • Drug Candidate Profiles
  • Staphylococcal Infections - Therapeutics Assessment
  • Assessment by Monotherapy Products
  • Assessment by Combination Products
  • Assessment by Route of Administration
  • Assessment by Molecule Type
  • Staphylococcal Infections - Discontinued Products
  • Staphylococcal Infections - Dormant Products
  • Companies Involved in Therapeutics Development for Staphylococcal Infections

For more information visit http://www.researchandmarkets.com/research/rxjsbd/staphylococcal

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals